EDMONTON, Alberta, Feb. 6 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it will start a "LIVE" testing program in Texas with its VScan Hepatitis C rapid test kit. Medical Services received approval under an IRB to begin "Live" testing of its VScan Hepatitis C test kit. The test will begin in the next several weeks and be performed by a major university in Texas. The procedures and protocols related to the IRB to be used during the testing have been approved by regulatory authorities.
There has been preliminary testing completed prior to this testing program. During the preliminary program, the VScan Hepatitis C diagnostic test kit was found to be accurate (greater than 99%), fast and easy to use in the field. Upon the successful completion of this testing, the Company will begin the process of filing for approval with regulatory agencies in the United States. This test data will also be used to apply for regulatory approval in other parts of the world. It is reported in published literature that there are over 200 million people that have Hepatitis C and do not know it. A rapid test kit will be instrumental in reducing the spread of Hepatitis C.
Market studies show that there will be a large demand for a rapid test kit for Hepatitis C that can be used in privacy of your own home. In addition to that demand, governments are looking for a rapid test for Hepatitis C that can be used in remote areas and is accurate and easy to use.
About VScan
The VScan rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or www.medicalservicesintl.com or www.minerva-biotech.com .
NOTE: Certain statements in this press release are "forward-looking statements within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Medical Services International Inc.CONTACT: Robert Talbot, +1-780-430-6363, or media contact, Bill Whitehead,+1-416-822-5883, both of Medical Services International Inc.